Pharmacology of protein kinase inhibitors.

[1]  H. Hidaka,et al.  The modulatory role of myosin light chain phosphorylation in human platelet activation. , 1986, Biochemical and biophysical research communications.

[2]  T. Soderling,et al.  Reversible generation of a Ca2+-independent form of Ca2+(calmodulin)-dependent protein kinase II by an autophosphorylation mechanism. , 1986, The Journal of biological chemistry.

[3]  E. Chambaz,et al.  Selective inhibition of a cyclic nucleotide independent protein kinase (G type casein kinase) by quercetin and related polyphenols. , 1982, Biochemical pharmacology.

[4]  E. Krebs,et al.  An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. , 1968, The Journal of biological chemistry.

[5]  L. Mcphail,et al.  Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine. , 1987, Journal of immunology.

[6]  T. Molski,et al.  The diacylglycerol kinase inhibitor R59022 potentiates superoxide production but not secretion induced by fMet-Leu-Phe: effects of leupeptin and the protein kinase C inhibitor H-7. , 1987, Biochemical and biophysical research communications.

[7]  M. Harbers,et al.  Tumor promotion and depletion of protein kinase C in epidermal JB6 cells. , 1989, Biochemical and biophysical research communications.

[8]  J. Patrick,et al.  Nerve growth factor mediates phosphorylation of specific proteins , 1980, Cell.

[9]  P. Greengard,et al.  Protein kinases in the brain. , 1985, Annual review of biochemistry.

[10]  A. Edelman,et al.  Protein serine/threonine kinases. , 1987, Annual review of biochemistry.

[11]  H. Sano,et al.  Calphostins, novel and specific inhibitors of protein kinase C. II. Chemical structures. , 1989, The Journal of antibiotics.

[12]  G M Hathaway,et al.  Cyclic nucleotide-independent protein kinases from rabbit reticulocytes. Purification of casein kinases. , 1979, The Journal of biological chemistry.

[13]  K. Umezawa,et al.  Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus. , 1989, Journal of natural products.

[14]  O. H. Griffith,et al.  Protein kinase C inhibitor H‐7 alters the actin cytoskeleton of cultured cells , 1989, Journal of cellular physiology.

[15]  T. Yamauchi,et al.  Purification and Cahracyterization of te Brain Calmodulin-Dependent Protein Kinase (Kinase II), Which Is involved in the Activtion of Tryptophan 5-Monooxygnase , 1983 .

[16]  D. Hartshorne,et al.  Modulator protein as a component of the myosin light chain kinase from chicken gizzard. , 1978, Biochemistry.

[17]  M. Hagiwara,et al.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.

[18]  R. Seifert,et al.  Stimulus-dependent inhibition of platelet aggregation by the protein kinase C inhibitors polymyxin B, H-7 and staurosporine. , 1988, Biochemical and biophysical research communications.

[19]  Y. Hannun,et al.  Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. , 1986, The Journal of biological chemistry.

[20]  S. Pandol,et al.  1,2-Diacylglycerol, protein kinase C, and pancreatic enzyme secretion. , 1986, The Journal of biological chemistry.

[21]  H. Kawasaki,et al.  Tissue-specific expression of three distinct types of rabbit protein kinase C , 1987, Nature.

[22]  G. Denis,et al.  Concanavalin A- and calcium-dependent phosphorylation of a protein of 80 kDa in mouse lymphocytes rendered permeable to exogenously added [gamma-32P]ATP. , 1986, Biochimica et biophysica acta.

[23]  M. Kennedy,et al.  Regulation of brain Type II Ca 2+ calmodulin -dependent protein kinase by autophosphorylation: A Ca2+-triggered molecular switch , 1986, Cell.

[24]  J. Westwick,et al.  Activation of protein kinase C inhibits sodium fluoride-induced elevation of human platelet cytosolic free calcium and thromboxane B2 generation. , 1986, Biochemical and biophysical research communications.

[25]  J. Ishida,et al.  A specific inhibitor for tyrosine protein kinase from Pseudomonas. , 1986, The Journal of antibiotics.

[26]  H. Hidaka,et al.  A selective Ca2+/calmodulin-dependent protein kinase II inhibitor, KN-62, inhibits the enhanced phosphorylation and the activation of tyrosine hydroxylase by 56 mM K+ in rat pheochromocytoma PC12h cells. , 1991, Biochemical and biophysical research communications.

[27]  T. Tanaka,et al.  N-(6-phenylhexyl)-5-chloro-1-naphthalenesulfonamide is one of a new class of activators for Ca2+-activated, phospholipid-dependent protein kinase. , 1986, Biochimica et biophysica acta.

[28]  J. Hakim,et al.  Negative effect of a protein kinase C inhibitor (H-7) on human polymorphonuclear neutrophil locomotion. , 1988, Immunology.

[29]  H. Ogawara,et al.  Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones. , 1989, The Journal of antibiotics.

[30]  P. Cohen,et al.  Phosphorylation of tyrosine hydroxylase by calmodulin-dependent multiprotein kinase. , 1984, The Journal of biological chemistry.

[31]  H. Hidaka,et al.  Effects of KN-62, a specific inhibitor of calcium/calmodulin-dependent protein kinase II, on long-term potentiation in the rat hippocampus , 1991, Neuroscience Letters.

[32]  Y. Matsuda,et al.  K-252a, a potent inhibitor of protein kinase C from microbial origin. , 1986, The Journal of antibiotics.

[33]  K. Okumura,et al.  A calmodulin antagonist (W-7) and a protein kinase C inhibitor (H-7) have no effect on atrial natriuretic peptide release induced by atrial stretch. , 1988, Life sciences.

[34]  T. Tamaoki,et al.  UCN-1028A, a novel and specific inhibitor of protein kinase C, from Cladosporium. , 1989, The Journal of antibiotics.

[35]  P. Greengard,et al.  Autophosphorylation reversibly regulates the Ca2+/calmodulin-dependence of Ca2+/calmodulin-dependent protein kinase II. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T Takeuchi,et al.  Inhibition of tyrosine protein kinase by synthetic erbstatin analogs. , 1987, The Journal of antibiotics.

[37]  C. Wright,et al.  The protein kinase C inhibitors H-7 and H-9 fail to inhibit human neutrophil activation. , 1986, Biochemical and biophysical research communications.